CNTA

Centessa Pharmaceuticals plcNASDAQHealthcare

$39.69-0.43%ClosedMarket Cap: $5.34B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-04-02	Guggenheim	—	Neutral	—
2026-04-01	Leerink Partners	—	Market Perform	—
2026-03-31	Wolfe Research	—	Peer Perform	—
2026-03-31	Needham	—	Hold	—
2026-01-29	Truist Securities	—	Buy	—
2026-01-02	Chardan Capital	—	Buy	—
2025-12-10	Oppenheimer	—	Outperform	—
2025-12-01	B. Riley Securities	—	Buy	—
2025-11-18	Guggenheim	—	Buy	—
2025-11-13	Wells Fargo	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Thu Dec 31	$-1.65	$3.1M	9
Fri Dec 31	$-1.76	$33.3M	8
Sun Dec 31	$-1.50	$149.9M	11
Mon Dec 31	$-0.15	$384.6M	4